FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

412077000: Adrenal hormone agent (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2467529014 Adrenal hormone agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2473681016 Adrenal hormone agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2467529014 Adrenal hormone agent (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2467529014 Adrenal hormone agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2473681016 Adrenal hormone agent en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2473681016 Adrenal hormone agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Adrenal hormone agent Is a Adrenal hormone false Inferred relationship Existential restriction modifier (core metadata concept)
    Adrenal hormone agent Is a allergène médicamenteux false Inferred relationship Existential restriction modifier (core metadata concept)
    Adrenal hormone agent Has disposition Adrenal hormone (disposition) false Inferred relationship Existential restriction modifier (core metadata concept)
    Adrenal hormone agent Is a Hormone false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Tramazoline hydrochloride+dexamethasone isonicotinate (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Mometasone furoate monohydrate 0.05% aqueous nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide 1 mg/g oromucosal paste The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone (as hydrocortisone sodium succinate) 2.5 mg oromucosal lozenge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone creams (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone 1 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone ointments The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone acetate 10 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Crotamiton 100 mg/g and hydrocortisone 2.5 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fusidic acid 20 milligram/1 gram and hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Econazole nitrate 10 mg/g and hydrocortisone 10 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely clotrimazole 10 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone acetate 10 mg/g and neomycin sulfate 5 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Alclometasone dipropionate 0.05% cream (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Alclometasone dipropionate 500 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclometasone dipropionate 250 microgram/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone valerate 0.12% foam (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone 0.1% scalp application (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone 0.1% cream (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone 0.1% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone 0.1% lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone+salicylic acid 0.05/3% scalp application The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone 0.05% cream (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone+neomycin sulfate 0.1/0.5% ointment (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely clobetasone butyrate 500 microgram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clobetasone butyrate 500 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Desoxymethasone 0.05% oily cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Diflucortolone valerate 1 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Diflucortolone valerate 0.1% oily cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Diflucortolone valerate 1 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Diflucortolone valerate 0.3% oily cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Diflucortolone valerate 0.3% ointment (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide 62.5 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide 0.00625% cream (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide 25 microgram/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinolone acetonide 250 microgram/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocortolone 0.5% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocortolone 0.5% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fludroxycortide 125 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely halcinonide 1 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone butyrate 1 mg/g cutaneous emulsion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone butyrate 1 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone butyrate 0.1% lipocream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone butyrate 0.1% scalp lotion (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone acetonide+chlortetracycline hydrochloride 0.1/3% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Mometasone furoate 1 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Mometasone furoate 1 mg/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 0.05% cream (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 50 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone+clotrimazole 0.05/1% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Ciprofloxacin- and dexamethasone-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clobetasol propionate 500 microgram/mL cutaneous lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone acetate 20 mg/mL cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate+salbutamol (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing betamethasone and clioquinol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone- and clotrimazole-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing betamethasone and fusidic acid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone+neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing betamethasone and salicylic acid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clobetasol propionate+neomycin sulfate+Nystatin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing clobetasone butyrate and neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clobetasone butyrate+oxytetracycline+nystatin (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fusidic acid- and hydrocortisone-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Gentamicin- and hydrocortisone-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing hydrocortisone and pramocaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing hydrocortisone and sodium fusidate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clorquinaldol- and hydrocortisone-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Chloramphenicol- and hydrocortisone-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing clioquinol and hydrocortisone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing clotrimazole and hydrocortisone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing crotamiton and hydrocortisone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)

    Start Previous Page 3 of 9 Next End

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start